Diana Marcela Mejía Granados
Diana Marcela Mejía Granados has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Benilton Carvalho
Department of Oncology, University of Cambridge, CRUK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK
1 shared publication Carlos Eduardo Steiner
Department of Medical Genetics and Genomic Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
1 shared publicationCarmen Silvia Bertuzzo
Department of Medical Genetics and Genomic Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
1 shared publication- Clarissa Lin Yasuda
Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brazil
1 shared publication - Fernando Cendes
Department of Neurology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil
1 shared publication - Iscia Lopes-Cendes
Department of Medical Genetics and Genomic Medicine, School of Medical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil
1 shared publication
Latest Publications
- Open Access
- 28 May 2026
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1)
Intestinal microbial community assessment in patients with different forms of epilepsy and autoimmune encephalitis: An exploratory study
1. The International League Against Epilepsy (ILAE) defines epilepsy as a group of chronic, heterogeneous, multifactorial disorders characterized by a persistent predisposition to generate spontane...
- 28 May 2026
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1)
Open AccessIntestinal microbial community assessment in patients with different forms of epilepsy and autoimmune encephalitis: An exploratory study
1. The International League Against Epilepsy (ILAE) defines epilepsy as a group of chronic, heterogeneous, multifactorial disorders characterized by a persistent predisposition to generate spontane...
- Open Access
- 1 January 2020
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 13, 1-10
Clinical and Molecular Investigation of Familial Multiple Lipomatosis: Variants in the HMGA2 Gene
Background: Familial multiple lipomatosis (FML) is an autosomal dominant disorder characterized by the slow growth of encapsulated nodules spread across the trunk and limbs. Currently, there is no specific etiology; therefore, its molecular and biological bases need to be better understood. High-throughput sequencing technologies appear to be a cost-effective tool and have a pivotal role in elucidating different genodermatoses. Objective: This study aimed to perform a clinical and molecular characterization of constitutional DNA of seven individuals belonging to five unrelated families diagnosed with FML. Patients and methods: Clinical aspects were obtained from medical records and physical examination. HMGA2 gene was investigated using Sanger sequencing method. Mutational analysis of other genes associated with syndromic lipomatosis AKT1, APC, PIK3CA, MEN-1, and PTEN was performed through next-generation sequencing. Results: In this series, FML was predominant among women who were overweight and reaching the age of thirty and was associated with gastrointestinal comorbidity. Histopathological diagnosis of biopsies revealed typical features of both lipoma and angiolipoma. We identified two identical novel variants with unknown significance in exon 5 of the HMGA2 gene in two participants of different families. There were no additional changes in exons 1 to 4 of the HMGA2 gene. Multi-gene panel was normal in all cases. Conclusion: Variants found in exon 5 of the HMGA2 gene have not been described and have an uncertain significance in the genesis of FML. Further studies, including a more significant number of affected individuals and functional analysis of the novel variants of HGMA2 gene, should be undertaken to better understand its biological role in FML.
- 1 January 2020
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 13, 1-10
Open AccessClinical and Molecular Investigation of Familial Multiple Lipomatosis: Variants in the HMGA2 Gene
Background: Familial multiple lipomatosis (FML) is an autosomal dominant disorder characterized by the slow growth of encapsulated nodules spread across the trunk and limbs. Currently, there is no specific etiology; therefore, its molecular and biological bases need to be better understood. High-throughput sequencing technologies appear to be a cost-effective tool and have a pivotal role in elucidating different genodermatoses. Objective: This study aimed to perform a clinical and molecular characterization of constitutional DNA of seven individuals belonging to five unrelated families diagnosed with FML. Patients and methods: Clinical aspects were obtained from medical records and physical examination. HMGA2 gene was investigated using Sanger sequencing method. Mutational analysis of other genes associated with syndromic lipomatosis AKT1, APC, PIK3CA, MEN-1, and PTEN was performed through next-generation sequencing. Results: In this series, FML was predominant among women who were overweight and reaching the age of thirty and was associated with gastrointestinal comorbidity. Histopathological diagnosis of biopsies revealed typical features of both lipoma and angiolipoma. We identified two identical novel variants with unknown significance in exon 5 of the HMGA2 gene in two participants of different families. There were no additional changes in exons 1 to 4 of the HMGA2 gene. Multi-gene panel was normal in all cases. Conclusion: Variants found in exon 5 of the HMGA2 gene have not been described and have an uncertain significance in the genesis of FML. Further studies, including a more significant number of affected individuals and functional analysis of the novel variants of HGMA2 gene, should be undertaken to better understand its biological role in FML.